mutLBSgeneDB |
Gene summary for FOXM1 |
Gene summary |
Basic gene Info. | Gene symbol | FOXM1 |
Gene name | forkhead box M1 | |
Synonyms | FKHL16|FOXM1B|HFH-11|HFH11|HNF-3|INS-1|MPHOSPH2|MPP-2|MPP2|PIG29|TGT3|TRIDENT | |
Cytomap | UCSC genome browser: 12p13 | |
Type of gene | protein-coding | |
RefGenes | NM_001243088.1, NM_001243089.1,NM_021953.3,NM_202002.2,NM_202003.2, | |
Description | Forkhead, drosophila, homolog-like 16HNF-3/fork-head homolog 11M-phase phosphoprotein 2MPM-2 reactive phosphoprotein 2forkhead box protein M1forkhead-related protein FKHL16hepatocyte nuclear factor 3 forkhead homolog 11transcription factor Trident | |
Modification date | 20141222 | |
dbXrefs | MIM : 602341 | |
HGNC : HGNC | ||
Ensembl : ENSG00000111206 | ||
HPRD : 03823 | ||
Vega : OTTHUMG00000168118 | ||
Protein | UniProt: Q08050 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_FOXM1 | |
BioGPS: 2305 | ||
Pathway | NCI Pathway Interaction Database: FOXM1 | |
KEGG: FOXM1 | ||
REACTOME: FOXM1 | ||
Pathway Commons: FOXM1 | ||
Context | iHOP: FOXM1 | |
ligand binding site mutation search in PubMed: FOXM1 | ||
UCL Cancer Institute: FOXM1 | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0000086 | G2/M transition of mitotic cell cycle | 19160488 | GO:0006355 | regulation of transcription, DNA-templated | 10523841 | GO:0006366 | transcription from RNA polymerase II promoter | 9032290 | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 19160488 |
Top |
Ligand binding site mutations for FOXM1 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | S306 | V305L | COAD | 1 | S240 | S240C | COAD | 1 | Y241 | M242K | LUAD | 1 | H287,L289 | N288S | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for FOXM1 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | Y241 | M242K | -1.1875125 | S240 | S240C | -0.82407462 | S306 | V305L | -0.70243501 | L289 | N288S | -0.23915106 | H287 | N288S | -0.23915106 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for FOXM1 from PDB |
Top |
Differential gene expression and gene-gene network for FOXM1 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for FOXM1 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C2239176 | Carcinoma, Hepatocellular | 18 | Biomarker |
umls:C0007131 | Carcinoma, Non-Small-Cell Lung | 9 | Biomarker |
umls:C0024121 | Lung Neoplasms | 6 | Biomarker, GeneticVariation |
umls:C1458155 | Breast Neoplasms | 3 | AlteredExpression, Biomarker |
umls:C0023418 | Leukemia | 2 | Biomarker |
umls:C0017661 | Glomerulonephritis, IGA | 1 | Biomarker |
umls:C0023904 | Liver Neoplasms, Experimental | 1 | Biomarker |
umls:C0032927 | Precancerous Conditions | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for FOXM1 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of FOXM1 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | NUC | Nucleic Acids | 3g73 | A | H287 S306 | NUC | Nucleic Acids | 3g73 | B | H287 S306 | MG | MAGNESIUM(2+) | 3g73 | A | L289 | MG | MAGNESIUM(2+) | 3g73 | B | L289 | NUC | Nucleic Acids | 3g73 | A | S240 Y241 H287 | NUC | Nucleic Acids | 3g73 | B | S240 Y241 H287 |
Top |
Conservation information for LBS of FOXM1 |
Multiple alignments for Q08050 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |